RJF

Raymond James Financial
Investment Banking & Brokerage · Financials · as of 2026-10-05
Last close
$160.80
+1.6% on the session
1-year return
-2.0%
+14.2% over six months
Volatility
25.0%
annualized, trailing year
Max drawdown
-18.9%
worst peak to trough, 1y
What the numbers say

Raymond James Financial is a investment banking & brokerage name in the financials sector. Over the past year it returned -2.0%, against -3.7% over three months and -10.9% over one. It sits just 0.7% above its 200-day average, technically in an uptrend, but without much room. Annualized volatility of 25.0% is moderate by single-stock standards.

Its worst peak-to-trough decline over the year was -18.9%, and it has traded a median $190M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.39 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Financials#32 of 74
Stronger than 58% of its sector on the momentum profile
Across the whole index#222 of 496

How RJF scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 5 others in Investment Banking & Brokerage.

Start a free 7-day trial
Full metrics
1 day+1.6%
1 week+0.1%
1 month-10.9%
3 months-3.7%
6 months+14.2%
1 year-2.0%
12-1 momentum+10.0%
Volatility (1y, annualized)25.0%
Max drawdown (1y)-18.9%
Distance vs 200-day average+0.7%
Return per unit of risk-0.08
Median daily dollar volume$190M
Free newsletter

Get RJF when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.